Marinus Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
MRNS Marinus Pharmaceuticals Inc
ORGO Organogenesis Holdings Inc
FOLD Amicus Therapeutics Inc
$NYGCAREURN Nasdaq Yewno Global Future Mobility
HGSH China HGS Real Estate Inc
PFE Pfizer Inc
DG Dollar General Corp
AMT American Tower Corp
SWKS Skyworks Solutions Inc
ADI Analog Devices Inc
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Marinus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders. Its clinical-stage product candidate, ganaxolone, is a modulator being developed in various dose forms, including intravenous, oral capsule and oral liquid, intended to provide more treatment options to adult and pediatric patient populations in both acute and chronic care settings. Ganaxolone acts on the GABAA receptor, a target in the brain known for both anti seizure and anti anxiety effects through positive allosteric modulation. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19 pediatric epilepsy.

Postmarket

Last Trade
Delayed
$3.14
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$3.14
Day's Change
-0.07 (-2.18%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
3.22
Day's Low
2.96
Volume
(Light)
Volume:
3,759,205

10-day average volume:
20,909,407
3,759,205
  • Prev Close
    3.21
  • Today's Open
    3.14
  • Day's Range
    2.96-3.22
  • Avg Vol (10-day)
    20.9M
  • Last (time)
    4:00p ET 09/22/20
  • Last (size)
    2
  • 52-Wk Range
    1.01 - 4.07
    LowHigh
  • (11/20/19 - 09/15/20)
    22.85%
  • 123.9%
  • Market Cap
    383.7M
  • Shares Outstanding
    122.2M
  • -0.99
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.5
  • 75.74
  • (% of float 08/31/20)
    12.48

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.